ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163062 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163062; 2) Community: the network communities that were significantly associated with the response to NSC 163062; 3) Molecule: the relationships between components within communities and NSC 163062; 4) MDR: the compounds that were significantly associated with the NSC 163062.

NSC Compound Enrichment Correlation
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0403978426119736 0.32321132
NSC 732859 2-chloro-1-(benzenesulfonyl)piperidine-4-carboxilic acid biphenylamide. 0.040397842611974 -0.0014274377
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0403978426119741 0.13610999
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0403978426119741 0.10219396
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0403978426119741 0.20628294
NSC 269760 B8 0.0403978426119741 0.29761887
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0403978426119741 0.18320882
NSC 303861 L-Cysteine analog 0.0403978426119741 0.4047944
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0403978426119741 0.18855947
NSC 321240 Null 0.0403978426119741 0.2285286
Total:156  Current:138    [First] [Prev] [Next] [Last]